Publication date: September–October 2026 Source: Ophthalmology Glaucoma, Volume 9, Issue 5 Author(s): Abdelrahman M. Elhusseiny, Marie Michele Macaron, Amr K. Hassan, Ta C. Chang
Adverse Events and Intraocular Pressure–Lowering Effect of Topical 0.5% Apraclonidine in Childhood Glaucoma: A Retrospective Single-Center Study. // Ophthalmology Glaucoma. – URL: https://www.sciencedirect.com/science/article/pii/S2589419626000323?dgcid=rss_sd_all
Adverse Events and Intraocular Pressure–Lowering Effect of Topical 0.5% Apraclonidine in Childhood Glaucoma: A Retrospective Single-Center Study. Ophthalmology Glaucoma. https://www.sciencedirect.com/science/article/pii/S2589419626000323?dgcid=rss_sd_all
“Adverse Events and Intraocular Pressure–Lowering Effect of Topical 0.5% Apraclonidine in Childhood Glaucoma: A Retrospective Single-Center Study.” Ophthalmology Glaucoma.
@article{article61367,
title = {Adverse Events and Intraocular Pressure–Lowering Effect of Topical 0.5\% Apraclonidine in Childhood Glaucoma: A Retrospective Single-Center Study},
journal = {Ophthalmology Glaucoma},
url = {https://www.sciencedirect.com/science/article/pii/S2589419626000323?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...